ERBB2 and neoplasm: The DL-assisted change was insignificant TNBCs, possibly due to the relatively small number of datasets, because we had validated that our DL model could well-distinguish tumor cells and lymphoid cells not only in HER2-positive tumors but also in TNBCs.